About VIGOROUS AGE
VIGOROUS AGE is a brand of children’s nutritional supplements in the Philippines, primarily marketed as growth vitamins in gummy form. The product has been promoted to parents as a food supplement intended to support childhood growth, bone development, and general nutrition.
In October 2023, the Philippine Food and Drug Administration (FDA) issued a public warning identifying VIGOROUS AGE Growth Vitamins Dietary Supplement as an unregistered product that did not possess a Certificate of Product Registration (CPR) at the time of verification. The agency stated that because the product had not undergone its evaluation process, it could not assure the public of its quality, safety, or compliance. This regulatory action remains the most significant documented event in the brand’s public history.
Brand overview
| Category | Information |
|---|---|
| Brand name | VIGOROUS AGE |
| Product category | Children’s food supplement / growth vitamins |
| Primary market identified | Philippines |
| Target consumers | Children and their parents or caregivers |
| Product format reported | Gummy / vitamin supplement |
| Marketing focus | Growth, nutrition, bones and teeth |
| Regulatory status reported in 2023 | FDA warning; product identified as unregistered at that time |
| Known CPR at the time of FDA warning | None identified by the FDA |
| Official corporate history | Not sufficiently documented in reliable public sources |
Products and positioning
VIGOROUS AGE has primarily appeared in online listings as a children’s growth vitamin. Product descriptions identify the supplement as a gummy-form vitamin product for children. An Australian eBay listing, for example, identifies the product as “VIGOROUS AGE Growth Vitamins kids Gummie” and classifies it as a vitamin in gummy formulation [1].
Consumer content in the Philippines has previously described VIGOROUS AGE as a food supplement for children whose parents are concerned about slow growth. Such materials have associated the product with vitamin D and vitamin B12, claiming benefits related to growth-hormone secretion, bone and dental health, and nutrient absorption. These statements are marketing or editorial claims rather than established clinical conclusions.
Target market
The apparent target market of VIGOROUS AGE consists of Filipino families with children, particularly parents seeking nutritional supplementation during periods of childhood growth. Its positioning differs from conventional adult multivitamins because public marketing focuses specifically on height, physical growth, bone development, and childhood nutrition.
Marketing claims
Public descriptions of VIGOROUS AGE have included claims concerning:
- Supporting children’s physical growth
- Supporting bone development
- Supporting healthy teeth
- Providing vitamins associated with childhood nutrition
- Supporting the body’s absorption or utilization of nutrients
- Promoting the secretion of human growth hormone
Claims regarding growth hormone secretion require particular caution. A vitamin supplement should not be interpreted as a treatment for growth disorders or as a substitute for medical evaluation of short stature. Children’s height is influenced by genetics, nutrition, hormones, chronic illness, sleep, and other factors.
Regulatory history in the Philippines
The most significant documented event in the brand’s public history is a Philippine FDA warning issued in 2023. The FDA’s post-marketing surveillance identified VIGOROUS AGE Growth Vitamins Dietary Supplement as a product that was not registered with the agency and did not have the required Certificate of Product Registration at the time of the warning. The FDA advised the public and health professionals against purchasing or consuming the product and warned establishments against manufacturing, distributing, advertising, or selling the product without appropriate authorization.
The FDA maintained that an unregistered health product had not undergone the agency’s evaluation process, meaning the agency could not provide assurance regarding its quality, safety, or compliance. This regulatory history is relevant when evaluating VIGOROUS AGE, as online listings or consumer reviews do not constitute evidence of current FDA authorization.
Public presence
VIGOROUS AGE has appeared on Philippine e-commerce and social-commerce channels, including listings for children’s food supplements. A local parenting article previously included the product among children’s supplement brands and listed a price of approximately ₱489 at the time of publication. Prices and availability may change substantially over time.
The brand has also appeared in overseas resale listings, indicating that products marketed under the VIGOROUS AGE name have circulated outside the Philippines [1].
Brand identity
The name “VIGOROUS AGE” suggests a positioning centered on vitality, strength, youth, and healthy development. In the context of its children’s products, the name aligns with a marketing strategy emphasizing the active growth stage of childhood.
However, publicly available sources do not provide sufficient reliable information to establish the exact founding year, original founders, registered owner, parent company, manufacturing company, headquarters location, complete product portfolio, current corporate ownership, or current Philippine FDA registration status. These details should not be presented as established facts without additional primary documentation.
Controversy and consumer considerations
The principal documented controversy regarding VIGOROUS AGE is its regulatory status in the Philippines. The 2023 FDA warning is significant because it concerns the legal authorization and regulatory evaluation of the product. The FDA specifically stated that the product lacked a Certificate of Product Registration at that time and had not undergone the agency’s evaluation process.
Consequently, claims made in advertisements, marketplace listings, social media posts, or informal reviews should be distinguished from evidence generated through recognized clinical or regulatory evaluation. Parents considering nutritional supplements for children should distinguish between general nutritional supplementation and products marketed as influencing height or growth hormone. Persistent concerns about a child’s growth are more appropriately evaluated by a pediatrician rather than addressed solely through an over-the-counter supplement.
Current status
As of the publicly documented information available for this profile, the clearest regulatory record concerning VIGOROUS AGE is the Philippine FDA warning from 2023. There is no sufficiently authoritative public documentation establishing that the product subsequently obtained a Philippine FDA Certificate of Product Registration.
Therefore, the regulatory status of VIGOROUS AGE should be described cautiously. Claims regarding its effectiveness, safety, regulatory approval, or ability to increase children’s height should be treated carefully and separated from the brand’s marketing claims. Based on currently available sources, VIGOROUS AGE should not be described as an established pharmaceutical, medically proven growth treatment, or FDA-approved supplement.
